SCHEMBL16902387

SCHEMBL16902387

c1ccc(-c2nc(-c3ccccc3)c3c(n2)oc2ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ ATM Q13315 1/20 0.43
▸ MAPT P10636 5/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ HTT P42858 2/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ PDGFRB P09619 1/20 0.42
▸ KIT P10721 1/20 0.42
▸ FLT3 P36888 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ WHR1 P49842 1/20 0.40
▸ LMNA P02545 3/20 0.39
▸ ADK P55263 2/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ TSHR P16473 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18017923 0.98 MEN1 (0.45) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017879 0.98 MEN1 (0.45) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017783 0.98 MEN1 (0.45) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL16902590 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017795 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017797 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18370598 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017880 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL18017780 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2
SCHEMBL16902564 0.97 KMT2A (0.44) KMT2AMEN1ATMMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures MERCK PATENT GMBH (DE) 2024-07-09 — — US disclosed
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures MERCK PATENT GMBH (DE) 2024-07-09 — — US disclosed
US-11530224-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures MERCK PATENT GMBH (DE) 2022-12-20 — — US disclosed
EP-3519415-B1 CARBAZOLES WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2022-12-14 — — EP disclosed
EP-3519417-B1 COMPOUNDS WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2021-09-08 — — EP disclosed
WO-2018060307-A1 COMPOUNDS WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2018-04-05 — — WO disclosed
WO-2018060218-A1 CARBAZOLES WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2018-04-05 — — WO disclosed
WO-2015105316-A1 FUSED-RING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 삼성에스디아이 주식회사 2015-07-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12030890-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures DDT, ESD, DBF4 KMT2A 1118/4885MEN1 1774/4885ATM 4367/4885
US-11530224-B2 Compounds with diazadibenzofurane or diazadibenzothiophene structures DDT, ESD, DBF4 KMT2A 1118/4885MEN1 1774/4885ATM 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback